PetVivo Holdings, Inc. Achieves National Distribution of Spryng™ to More than 600 Veterinary Clinics in 49 States
This advance was demonstrated by the increase of veterinarian inquiries and podium speaker references related to Spryng at the American Association of Equine Practitioners (“AAEP”) conference over the past three years.
- This advance was demonstrated by the increase of veterinarian inquiries and podium speaker references related to Spryng at the American Association of Equine Practitioners (“AAEP”) conference over the past three years.
- SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles.
- Such action promotes the restoration of proper joint mechanics, thereby aiding in the management of lameness and other joint-related afflictions, such as osteoarthritis.
- “We are also seeing enthusiasm surrounding Spryng in the veterinary community with veterinarians sending us videos and images touting the benefits of Spryng,” said Mr. Lai.